Moogene Medi Co., Ltd. (XKON:322970)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,985.00
+55.00 (1.88%)
At close: May 8, 2026
Market Cap30.01B +25.7%
Revenue (ttm)12.95M -87.2%
Net Income-2.08B
EPS-332.00
Shares Out10.05M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume25
Average Volume1,194
Open2,990.00
Previous Close2,930.00
Day's Range2,815.00 - 2,990.00
52-Week Range1,720.00 - 3,790.00
Beta-0.28
RSI49.60
Earnings Daten/a

About Moogene Medi

Moogene Medi Co., Ltd. develops nanobiotechnology-based drug delivery systems. It develops lipid nanoparticle (LNP) materials for pharmaceutical protein delivery; RNP (sgRNA+ CRISPR Cas9)-encapsulated LNP for gene therapy; novel therapy for colorectal or pancreatic cancer with anticancer drug resistance due to genetic mutation by using RNP-encapsulated LNP; and topical treatment for androgenic alopecia therapy. The company was founded in 2016 and is headquartered in Hanam-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2016
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 322970
Full Company Profile